Plecanatide

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 119 publications

Plecanatide Is Efficacious in Women Aged 18 to 40 Years With IBS-C and Bloating: A Pooled Analysis of Two Phase 3, Randomized, Placebo-Controlled Trials.

Plecanatide Is Efficacious in Women Aged 18 to 40 Years With IBS-C and Bloating: A Pooled Analysis of Two Phase 3, Randomized, Placebo-Controlled Trials.

Journal: Gastroenterology & hepatology

Published: February 02, 2026

Improvement in Health-Related Quality of Life in Adults With IBS-C Not Achieving Bowel Movement Frequency Criterion: Analysis of Two Phase 3 Plecanatide Trials.

Improvement in Health-Related Quality of Life in Adults With IBS-C Not Achieving Bowel Movement Frequency Criterion: Analysis of Two Phase 3 Plecanatide Trials.

Journal: Gastroenterology & hepatology

Published: February 02, 2026

Real-World Safety Analysis of the Constipation-Predominant IBS Treatment Options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor.

Real-World Safety Analysis of the Constipation-Predominant IBS Treatment Options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor.

Journal: Gastroenterology & hepatology

Published: February 02, 2026

Reconsidering Multisymptom Composite Endpoints in IBS-C Trials.

Reconsidering Multisymptom Composite Endpoints in IBS-C Trials.

Journal: Journal of gastroenterology and hepatology

Published: January 08, 2026

Reconsidering Bloating as a Core Endpoint in IBS-C: Commentary on Brenner et al. (2025).

Reconsidering Bloating as a Core Endpoint in IBS-C: Commentary on Brenner et al. (2025).

Journal: Journal of gastroenterology and hepatology

Published: November 12, 2025

Based on the FDA Adverse Event Reporting System Database, a Study on Signal Mining of Adverse Events for Guanylate Cyclase-C Receptor Agonists.

Based on the FDA Adverse Event Reporting System Database, a Study on Signal Mining of Adverse Events for Guanylate Cyclase-C Receptor Agonists.

Journal: Hospital pharmacy

Published: October 16, 2025

Laxative logic: when lifestyle is not enough.

Laxative logic: when lifestyle is not enough.

Journal: Current opinion in gastroenterology

Published: September 29, 2025

Efficacy and tolerability of plecanatide for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis.

Efficacy and tolerability of plecanatide for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis.

Journal: European journal of gastroenterology & hepatology

Published: July 14, 2025

Constipation-predominant irritable bowel syndrome treatment options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor: analysis of the FDA Adverse Event Reporting System (FAERS) database.

Constipation-predominant irritable bowel syndrome treatment options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor: analysis of the FDA Adverse Event Reporting System (FAERS) database.

Journal: Expert opinion on drug safety

Published: June 12, 2025

Efficacy and safety of pharmacological therapies for functional constipation in children: a systematic review and meta-analysis.

Efficacy and safety of pharmacological therapies for functional constipation in children: a systematic review and meta-analysis.

Journal: The Lancet. Child & adolescent health

Published: June 09, 2025

The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint.

The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint.

Journal: Journal of gastroenterology and hepatology

Published: June 05, 2025

Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Drugs

Published: June 04, 2025

Showing 1-12 of 119

Last Updated: 04/28/2026